Poisson-Boltzmann (PB) model is one of the most popular implicit solvent models in biophysical modeling and computation. The ability of providing accurate and reliable PB estimation of electrostatic solvation free energy, ∆G el , and binding free energy, ∆∆G el , is important to computational biophysics and biochemistry. Recently, it has been warned in the literature (Journal of Chemical Theory and Computation 2013, 9, 3677-3685) indicate that the use of grid spacing 0.6 Å ensures accuracy and reliability in ∆∆G el calculation. In fact, the grid spacing of 1.1 Å appears to deliver adequate accuracy for high throughput screening.
the validity of using PB model for biomolecular electrostatic binding analysis at an affordable grid spacing of 0.5 Å.
In the past few years, there have been many attempts to develop highly accurate PB solvers using advance techniques for interface treatments. 16, [18] [19] [20] The later verison of the ACG solver 16, 18 has somewhat remedied the grid-dependence issue for estimates of binding energy. However, no confirmation for the reliable use of grid spacing of 0.5 Å in ∆∆G el has been given. In this work, we investigate the grid dependence of our PB solver (MIBPB) 21, 22 in estimating both electrostatic solvation free energies and electrostatic binding free energies. The MIBPB solver is by far the only existing method that is second-order accurate in L ∞ norm for solving the Poisson-Boltzmann equation with discontinuous dielectric constants, singular charge sources, and geometric singularities from the solvent excluded surfaces (SESs) of biomolecules. 21 Here the L ∞ norm means the maxmum absolute error measure and "second order accurate" means that the error reduces four times when the grid spacing is halved. Contrary to the findings in the literature, 15 our results indicate that the use of grid spacing 0.6 Å ensures accuracy and reliability in ∆∆G el calculation. In fact, a grid spacing of 1.1 Å appears to deliver adequate accuracy for high throughput screening. We therefore believe that when it is used properly, the PB methodology is able to deliver accurate and reliable electrostatic binding analysis.
Methods

MIBPB package
In the current work, we employ the our MIBPB package 21, 22 to predict the electrostatic solvation free energy. The MIBPB package is a second-order convergence PB solver for dealing with the SESs of biomolecules. Numerically, there are three major obstacles in constructing accurate and reliable PB solvers. First, commonly used solvent-solute interfaces, i.e., the van der Walls (vdW) surface, solvent accessible surface (SAS), and the solvent excluded surface (SES) 23, 24 admit geometric singularities, such as sharp tips, cusps and self-intersecting surfaces, 25 which make the rigorous enforcement of interface jump conditions a formidable task in PB solvers. An advanced mathematical interface techniques, the matched interface and boundary (MIB) method, [26] [27] [28] [29] [30] [31] is employed in the MIBPB package to achieve the second order accuracy in handling biomolecular SESs. Additionally, the atomic singular charges described by the delta functions give rise to another difficulty in constructing highly accurate PB solver. A Dirichlet-to-Neumann map technique has been developed in the MIBPB package to avoid the numerical approximation of singular charges by using the analytical Green's functions. 32 Finally, the nonlinear Boltzmann term can affect solver efficiency when handled inappropriately, particularly for BEMs. A quasi-Newton algorithm is implemented in the MIBPB package 21, 22 to take care the nonlinear term. 21,22
Interface generation
Many studies suggest that SES is able to deliver the state of the art accurate modeling of the solvated molecule. 7,9,13 As a result, much effort has been paid to developing an accurate and robust SES software. 25, 33 However, the MSMS software 25 generates a Lagrangian representation of the SES and is inconvenient for the Cartesian domain implementation of PB solvers. A Lagrangian to Eulerian transformation is required to convert MSMS surfaces for our Cartesian based MIBPB solver. 4 Most recently, we have developed a new SES software, Eulerian solvent excluded surface (ESES), to directly generate the SESs in the Eulerian representation. 34 Our ESES software enables the MIBPB solver to produce a reliable ∆G el . Both MSMS and ESES are supported by our MIBPB software. By increasing the MSMS surface density, the electrostatic solvation free energies calculated by using MSMS converge to those obtained by using ESES. 34 Therefore, only results employing ESES are shown in this work.
Data sets
In the present work, we adopt three sets of biomolecular complexes employed in the literature 15 for solvation free energy and binding free energy estimations. Specifically, the first set, Data Set 1, is a collection of DNA-minor groove drug complexes having a narrow range of ∆∆G.
The Protein Data Bank (PDB) IDs (PDBIDs) for this set are as follows: 102d, 109d, 121d,   127d, 129d, 166d, 195d, 1d30, 1d63, 1d64, 1d86, 1dne, 1eel, 1fmq, 1fms, 1jtl, 1lex, 1prp,   227d, 261d, 164d, 289d, 298d, 2dbe, 302d, 
Poisson-Boltzmann calculation details
The electrostatics binding free energy is a measure of binding affinity of two compounds due to the electrostatics interaction. Based on the free energy cycle, the electrostatics binding free energy can be calculated by the following formula 35
where (∆G el ) AB is the electrostatic solvation free energy of the bounded complex AB, (∆G el ) A and (∆G el ) B are the electrostatic solvation free energies of the unbounded components A and B, and (∆∆G el ) Coulomb is the electrostatic binding free energy of the two components in vacuum.
The electrostatic solvation free energies ∆G el are obtained by using MIBPB software 21, 22 while the binding energy (∆∆G el ) Coulomb is easily evaluated analytically via the following formula
where q i and q j are the corresponding charges of the given pair of atoms, and r i j is the distance between this pair. Here, ε m is the dielectric constant of the solute region. In all our calculations, the absolute temperature of the ionic solvent is chosen to be T = 298 K, the dielectric constants for solute and solvent are 1 and 80, and the ionic strength is 0.1 M NaCl.
The PBE is solved by the linearized solver, but the nonlinear one does not produce any notably differences. The incomplete LU biconjugate gradient squared (ILUBGS) solver is employed to solve all linear systems risen by the MIBPB approach. To maintain consistent computations of the PB solver at different grid sizes, the criteria convergence of ILUBGS solver measured by L 2 -norm is set to be 10 −6 , and the maximum iteration number is set to 100,000. The predictions of MIBPB solver on ∆G el and ∆∆G el are confirmed by other solvers such as PBSA, 10, 11 Delphi, 12, 13 and APBS 14 at the grid size of 0.2 Å, see Table S2 of Supporting Information.
Results and discussion
As described above, we consider three sets of binding complexes, namely, drug-DNA, barnasebarstar and RNA-peptide systems. For the sake of illustration, three sample surface electrostatic potentials, each from one distinct set, are depicted in Fig. 1 . PDBIDs for these three complexes 
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The influence of grid spacing in ∆G el estimation
We first examine the accuracy and robustness of our MIBPB solver in predicting the electrostatic solvation free energies of the aforementioned three data sets. Some previous literature 37, 38 has recognized that a grid size of h = 0.5 Å is small enough to produce a reliable ∆G el . Such an observation certainly remains for the MIBPB solver. In fact, our PB solver is able to deliver a very well-convergent calculations of electrostatic solvation free energies at as coarse grid sizes as 1.0 Å and 1.1 Å.
In the current calculations, the finest grid size is chosen to be 0.2 Å, and the coarser grid sizes are between 0.3 Å and 1.1 Å. Figure 2 depicts the correlations of ∆G el at various meshes for all complexes and unbounded components of three data sets. The electrostatic solvation free energies obtained at the finest grid spacing of 0.2 Å are plotted against those computed from coarser grid spacings of 0.3 Å, 0.7 Å and 1.1 Å. Obviously, the best fitting lines for these data at various coarse grid spacings produce near perfect alignments between the finest mesh results and those from coarse meshes. As shown in Table 1 Figure 3 illustrates the averaged relative absolute errors, i.e., the average of relative absolute errors designated in Eq. (??) over all the 153 discussed molecules, at different mesh sizes. It can be seen from Fig. 3 that the averaged relative absolute errors at all studied cases are less than 0.31%, and for any grid spacing smaller than 1.1 Å, these errors are always below 0.2%. This behavior further indicates the grid size independence of our PB solver over the normal grid-size range in molecular biophysical applications.
The influence of grid spacing in ∆∆G el estimation
Motivated by well-converged estimations of electrostatic solvation free energies at very coarse grid spacings as previously discussed, we are interested in predicting the binding free energies for all RNA-drug, barnase-barstar, and RNA-peptide complexes using our MIBPB package.
Similar to the study of the convergence of ∆G el , we correlate the binding free energy calculated at the finest grid spacing, h = 0.2 Å, and ones estimated at coarser mesh sizes, h = 0.3 Å, · · · , 1.1 Å. Figure 4 illustrates these relationships with the regression lines whose parameters are revealed in Table 2 . Since the previous discussion confirms MIBPB solver can produce very good R-squared values even at very coarse grid spacings, it is interesting to explore whether a similar behavior can be found for binding energy estimation. Indeed, the PB binding energy estimation behaves the same as the PB solvation calculation in our MIBPB technique. Specifically, R 2 is always 1 at the fine mesh, h = 0.3 Å. Moreover, these values are still satisfactory at relatively coarser mesh sizes.
For example, at the grid spacing of h = 1.1, the R 2 and slope of the regression line for DNA-drug, strongly support the reliable binding energy prediction of our solver at coarse grid sizes. Table 3 displays the binding free energy for all complexes with different grid spacings. As can be seen from Table 3 , the difference between binding energies at coarse meshes and the finest mesh, h = 0.2 Å, is mostly less than 10 kcal/mol for all complexes.
The trend of binding free energy at different grid spacings can be seen clearly in Figs. 5 which plots ∆∆G el against grid sizes varying between 0.2 Å and 1.1 Å for DNA-drug complexes. Similar figures for barnase-barstar and RNA-peptide complexes can be referred to Figs. S1 and S2 in the Supporting Information. Based on these figures, our solver can rank the binding free energy for DNA-drug complexes at grid spacing of 0.6 Å, barnase-barstar complexes at grid spacing of 0.6 Å, between results computed at a coarser grid spacing and the finest grid spacing defined by Figure 6 plots the averaged absolute errors, δ ∆∆G el , i.e., the average of absolute errors defined in Eq. (??) over all 51 complexes, at different mesh sizes. It is seen that even the use of grid spacing of 0.7 Å still delivers an averaged binding calculation error under 1 kcal/mol for this set of complexes. Therefore, we can draw a conclusion that the common use of grid size being 0.5 Å is still adequate for predicting the binding energy free without producing a misleading result.
Grid positioning error is another feature to validate the robustness and accuracy of a PB solver.
To examine such numerical error for our MIBPB solver, we consider two protein complexes with PDBIDs: 360d and 1hji. To estimate the standard deviation, σ bd in ∆∆G el , we randomly generate 29 grid positions around the initial origin with the amplitude of the random seed being ±0.5h, where h = 0.5 Å is the grid spacing. Then ∆∆G el is evaluated at all of the 30 grid positions. Note that in Table S2 of Supporting Information.
Concluding remarks
Poisson-Boltzmann (PB) theory is an established model for biomolecular electrostatic analysis and has been widely used in electrostatic solvation ∆G el and binding energy ∆∆G el estimations.
However, doubt has been cast on the validity of the commonly used grid spacing of 0.5 Å for producing converged estimates of ∆∆G el due to the unacceptable errors observed in the calculation using the solvent excluded surface (SES) and the adaptive Cartesian grid (ACG) finite difference PB equation solver. 15 Three sets of biomolecular complexes, namely, DNA-drug complexes, barnase-barstar complexes, and RNA-peptide complexes, are employed in the study. The discrepancies between results obtained from different surface definitions were also utilized to support the general pessimism for the PB methodology.
In this work, we employ the MIBPB software 21, 32 to estimate electrostatic solvation free energy, ∆G el , and binding free electrostatic energy, ∆∆G el , for the three sets of biomolecular complexes used in Ref. 15 The popular SES is adopted in the present work. In our ∆G el estimation, the averaged relative absolute error computed at a relatively coarse grid size of 1.1 Å against the finest grid size of 0.2 Å over 153 studied biomolecules is less than 0.31%. The same error obtained at the grid size of 1.0 Å is less than 0.2%. These results indicate the reliability of using the MIBPB solver at the grid spacing of 1.0 Å or even 1.1 Å for electrostatic solvation analysis. The robustness and accuracy of MIBPB solver for estimates of ∆G el have been reported for 24 proteins in the literature. 21, 32 This characteristics has been confirmed again in the present work for DNA-drug complexes, barnase-barstar complexes, and RNA-peptide complexes.
The well-converged ∆G el produced by our solver enables a promising performance in predicting ∆∆G el at a coarse grid spacing. Indeed, numerical estimates of ∆∆G el in the current work reveals that ∆∆G el obtained at a 1.1 Å grid spacing mostly differ by less than 10 kcal/mol from that achieved by using a 0.2 Å grid spacing. Moreover, MIBPB solver conducted at grid size of 0.6 Å perfectly produces a well-converged ∆∆G el , and qualitatively ranks the complexes in term of their binding free energies. Therefore, the current results support an opinion that the widely used grid size of 0.5 Å can give reliable and accurate enough predictions of both electrostatic free energy 39, 40 and binding free energy.
To develop highly accurate, robust and reliable PB solvers for biomolecular electrostatics, it is crucial to validate one's numerical methods by appropriate norms and against realistic problems.
We emphasize that as an elliptic interface problem, it is important to measure the convergence of PB solvers in the L ∞ norm, or maximum absolute error, because integral norms, such as L 1 and L 2 , are insensitive to the performance of numerical methods near the interface. Additionally, the convergence should be tested by solving the PB equation, rather than by calculating the solvation free energy. Finally, validation should be carried out by using the SESs of proteins, rather than smooth surfaces, such as a sphere. This material is available free of charge via the Internet at http://pubs.acs.org/.
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